CD34+

Ting Chen1, Xiaotong Sun2, Hui Gong2

  • 1Department of Cardiology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China; Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare, Hangzhou, China; Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Affiliated First Hospital of Ningbo University, Ningbo 315010, China.

概括

受体细胞在心脏移植后再生供体内皮,主要是通过CD34+原生细胞. 这些发现为改善长期移植结果和减少排斥提供了洞察力.